GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Vivani Medical Inc.
Vivani Medical develops miniature implants for long-term drug delivery. Its stock price is a venture bet on the success of this technology. The stock price reflects high volatility and dependence on the results of preclinical and clinical trials.
Share prices of companies in the market segment - Specialized medical equipment
Vivani Medical develops miniature subcutaneous implants for long-term drug delivery, primarily for the treatment of chronic diseases such as type 2 diabetes. We classify it as "Specialized Medical Equipment." The chart below shows the dynamics of this innovative segment.
Broad Market Index - GURU.Markets
Vivani Medical develops miniaturized implantable devices for long-term drug delivery. As an innovator in this field, it is included in our GURU.Markets index. The chart below shows the overall market trend. See how investors view this breakthrough technology.
Change in the price of a company, segment, and market as a whole per day
VANI - Daily change in the company's share price Vivani Medical Inc.
For Vivani Medical, Inc., a developer of implantable drugs, daily volatility reflects sensitivity to news about clinical trials. This metric is an important component in formulas that assess the risks and potential of companies in the innovative medical sector.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
For Vivani Medical, Inc., a developer of implantable drugs, daily volatility reflects sensitivity to news about clinical trials. This metric is an important component in formulas that assess the risks and potential of companies in the innovative medical sector.
Daily change in the price of a broad market stock, index - GURU.Markets
Vivani Medical develops miniature implants for long-term drug delivery for chronic conditions. It is an innovative company in the medical technology sector. Its shares reflect progress in this cutting-edge field and contribute to the overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Vivani Medical Inc.
Vivani Medical, Inc.'s annual performance is a story of miniaturized implantable medicinal devices. Its 12-month market cap depends entirely on progress in preclinical and clinical trials of its implant for the treatment of type 2 diabetes. Success could offer patients a new, convenient treatment option for up to six months.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Vivani Medical, Inc. is a biotech company developing miniature implants for long-term drug delivery. Its technology is aimed at treating chronic diseases. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough potential rather than its current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vivani, developing miniature drug delivery implants, is a speculative bet on the future of medicine. Its stock price isn't tied to the economy, but rather to its technological breakthroughs and partnerships. The chart tells the story of investors' faith that its innovation will transform the treatment of chronic diseases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Vivani Medical Inc.
Vivani Medical is developing miniature implants for long-term drug delivery. While still in the development stage, its monthly valuation is based on expectations. News of progress in preclinical and clinical trials of its implants for the treatment of diabetes and other chronic diseases are key drivers.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Vivani Medical, Inc. is a biopharmaceutical company developing miniaturized implantable devices for long-term drug delivery. The dynamics of its sector, shown in the chart, reflect innovation in medicine. Against this backdrop, one can assess the progress of its technology, designed to replace frequent injections for chronic diseases such as diabetes.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Vivani Medical develops implants for long-acting drug delivery. It's a medical startup whose stock moves on news of development progress. The stock price will exhibit high volatility and a weak correlation with the market, as investors evaluate the potential of future technology rather than current revenue.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Vivani Medical Inc.
Vivani Medical, a company developing miniature implants for long-term drug delivery, is experiencing high volatility. Weekly stock performance is driven by news about preclinical and clinical trials of its innovative platform, reflecting expectations for a breakthrough in the treatment of chronic diseases.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Vivani Medical is developing miniature implants for long-term drug delivery. This is an innovative approach in pharmacology. This chart will help compare how the market views its technology against the overall medical device sector and understand whether its performance reflects confidence in a future breakthrough.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Vivani Medical develops implants for long-term drug delivery. As a biotech company in the development stage, its shares are highly volatile. The chart shows that their dynamics are driven by news about the technology rather than general market trends.
Market capitalization of the company, segment and market as a whole
VANI - Market capitalization of the company Vivani Medical Inc.
Vivani Medical's market capitalization is a financial bet on the future of drug delivery. The stock price of this company, which develops miniature subcutaneous implants for the long-term delivery of diabetes medications, reflects its faith in this technology. Its volatility mirrors the hopes of freeing patients from daily injections.
VANI - Share of the company's market capitalization Vivani Medical Inc. within the market segment - Specialized medical equipment
Vivani Medical's market share in the specialized medical equipment sector is based on its innovative development—subcutaneous implants for long-term drug delivery. Its market share is a bet on the potential to transform the treatment of chronic diseases such as diabetes.
Market capitalization of the market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery. The chart below shows the overall market capitalization of the entire pharmaceutical industry. Its dynamics provide the backdrop against which Vivani is addressing the issue of patient adherence to chronic disease treatment.
Market capitalization of all companies included in a broad market index - GURU.Markets
Vivani Medical develops miniature subcutaneous implants for long-term drug delivery to treat chronic diseases such as diabetes. Its market capitalization is a bet on this technology. The chart below shows the economic impact of drug delivery innovations.
Book value capitalization of the company, segment and market as a whole
VANI - Book value capitalization of the company Vivani Medical Inc.
Vivani Medical, a developer of medical implants, derives its book value from its equity and R&D equipment. The chart below shows the financial resources for its innovative technology. Its level is an indicator of the company's ability to finance clinical trials and production preparation.
VANI - Share of the company's book capitalization Vivani Medical Inc. within the market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery. The company's value lies in its unique technology. The tangible asset share chart shows how it invests in R&D and pilot production to create its innovative physical platform.
Market segment balance sheet capitalization - Specialized medical equipment
Vivani Medical develops miniature implants for drug delivery. Its assets are not giant factories, but rather advanced R&D labs and pilot production lines for these devices. This is capital-intensive R&D. The chart illustrates how dependent the entire medical technology sector is on investments in innovation backed by physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Vivani Medical's balance sheet is comprised of capital invested in the development of miniature subcutaneous implants for long-term drug delivery. The company's assets represent the hope of creating a technology that could replace daily injections for chronic diseases such as diabetes.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Vivani Medical Inc.
Vivani Medical develops miniature implants for long-term drug delivery. The company has no revenue, and its value comes from its technology and patents. Its market capitalization is a pure bet on the commercial success of its implants. The chart shows how investors value this innovative approach to drug delivery.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery. It's an early-stage biotech company. Its entire value stems from investors' faith in its breakthrough technology. The chart shows how much its market valuation, based on this potential, exceeds its current tangible assets.
Market to book capitalization ratio for the market as a whole
Vivani Medical is developing miniature implants for long-term drug delivery. The chart shows how the market values this potentially breakthrough medical technology. The company's market capitalization reflects investors' bets that its implants will successfully pass clinical trials and provide more convenient and effective treatment for chronic diseases.
Debts of the company, segment and market as a whole
VANI - Company debts Vivani Medical Inc.
Vivani Medical is developing miniature implants for long-term drug delivery. This innovative technology requires significant investment in R&D and clinical trials. This chart shows how the company is raising capital, including debt, to bring its breakthrough technology to market.
Market segment debts - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery, designed to treat chronic diseases such as diabetes. This is a groundbreaking technology in pharmaceuticals. This chart provides insight into the industry's financial norms, where companies raise capital to conduct lengthy and expensive clinical trials of their breakthrough devices.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Vivani Medical Inc.
Vivani Medical develops miniature implants for long-term drug delivery. This innovative medical technology requires significant investment in research, testing, and regulatory approvals. This chart shows the extent to which the company finances its lengthy R&D cycle with debt, a direct indicator of its financial risk.
Market segment debt to market segment book capitalization - Specialized medical equipment
The development of implantable drug delivery systems like Vivani Medical's is a technology that has the potential to transform the treatment of chronic diseases. This chart shows the debt burden in the medical device sector. It allows one to assess how the financial model of a company developing breakthrough technology compares to the average for this capital-intensive industry.
Debt to book value of all companies in the market
Vivani Medical develops miniature implants for long-term drug delivery. Creating such complex medical devices is at the cutting edge of engineering and pharmacology, requiring significant investment. This chart shows how their debt-based R&D funding strategy compares to market norms.
P/E of the company, segment and market as a whole
P/E - Vivani Medical Inc.
This metric for Vivani Medical, Inc., a company developing implantable drug delivery devices, reflects its faith in its technology. For a company in the development stage, its value is determined not by current profits, but by the potential of its implants to transform the treatment of chronic diseases such as diabetes.
P/E of the market segment - Specialized medical equipment
This indicator represents the average valuation for the medical technology sector in which Vivani Medical operates. In this innovative industry, the average valuation can be high, reflecting expectations for future growth. It provides context for understanding how the market views Vivani's breakthrough implant technology.
P/E of the market as a whole
Vivani Medical is developing miniature implants for long-term drug delivery, for example, for the treatment of type 2 diabetes. This could eliminate the need for frequent injections. This chart shows the market's interest in medical innovations. It helps understand whether the market believes in the potential of Vivani's technology to change the standard of chronic disease treatment and what risks it is accepting.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Vivani Medical Inc.
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery, including for the treatment of type 2 diabetes. The company's future depends on the success of this technology in clinical trials. This chart reflects investor speculation regarding the potential of its innovative drug delivery system to improve the lives of patients with chronic diseases.
%20P%2FE%20Vivani%20Medical%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Vivani-Medical-Inc.&v=1772513904825 "Chart of the company's future (projected) P/E Vivani Medical Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery. The initial goal is to treat type 2 diabetes. This technology could eliminate the need for daily injections. The chart reflects expectations for the biotech sector, helping to assess the market's confidence in this promising, yet early-stage, technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772513904834 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Vivani Medical is developing miniature implants for long-term subcutaneous drug delivery, for example, for the treatment of diabetes. This is a promising, but early-stage technology. This graph of overall expectations demonstrates investor appetite for medical innovation. Market optimism and risk appetite are necessary to fund the development and clinical trials of such breakthrough devices.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513904836 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Vivani Medical Inc.
Vivani Medical develops miniature implants for long-term drug delivery to treat chronic diseases such as diabetes. This chart shows the biotech company's financial performance during the development stage. Revenue is a future goal, contingent on successful completion of clinical trials and approval of its innovative technology.
Profit of companies in the market segment - Specialized medical equipment
Laser Photonics Corp. produces industrial laser systems for cleaning, marking, and cutting. The company's profitability depends on investments in automation and production modernization. This chart shows how the demand for increased efficiency and precision in industry is creating a stable market for high-tech equipment manufacturers.
Overall market profit
Vivani Medical is developing miniature implants for long-term drug delivery, for example, for the treatment of type 2 diabetes. The company aims to replace daily injections with an implant that lasts for several months. Its success depends on the results of clinical trials and could revolutionize the treatment of chronic diseases.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Vivani Medical Inc.
Vivani Medical is developing miniature subcutaneous implants designed for long-term drug delivery, particularly for the treatment of type 2 diabetes. The company's revenue projections for the development stage are long-term. This graph reflects analyst expectations for the success of its technology and its potential to transform the treatment of chronic diseases.
%20profit%20of%20the%20company%20Vivani%20Medical%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Vivani-Medical-Inc.&v=1772513904865 "Graph of future (projected) profit of the company Vivani Medical Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery. The company's first goal is a six-month implant for the treatment of type 2 diabetes. This is an innovative approach to treating chronic diseases. This graph shows profitability forecasts for the pharmaceutical sector, reflecting the potential of breakthrough drug delivery technologies to change patients' lives.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772513904884 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Vivani Medical is developing miniature implants for long-term drug delivery, for example, for diabetes treatment. This is a cutting-edge medical technology, the success of which depends on clinical data. However, the overall profit forecast shown in this chart affects the investment climate and the healthcare system's willingness to implement new, potentially costly solutions.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513904902 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Vivani Medical Inc.
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery, particularly for the treatment of type 2 diabetes. The company is in the development stage and has no revenue. The company's earnings report reflects investors' confidence in the potential of its technology to dramatically improve patient adherence by replacing daily pills with a long-acting implant.
P/S market segment - Specialized medical equipment
Vivani Medical, Inc. is a biopharmaceutical company developing miniaturized implantable devices for long-term drug delivery to treat chronic diseases such as type 2 diabetes. This chart shows the average valuation for the sector, allowing one to assess the market's perception of the revenue potential of Vivani's innovative drug delivery technology.
P/S of the market as a whole
Vivani Medical is developing miniature implants for long-term drug delivery, particularly for the treatment of type 2 diabetes. This could eliminate the need for daily injections for patients. This chart, showing average valuations, clearly highlights the gap between the valuations of traditional businesses and companies developing breakthrough medical technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Vivani Medical Inc.
Vivani Medical develops miniature implantable devices for long-term drug delivery. This chart reflects investors' confidence in the future success of its technology. The valuation is based on expected revenue from its implant for the treatment of type 2 diabetes, which, if successful, could revolutionize the treatment of this disease.
%20P%2FS%20Vivani%20Medical%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Vivani-Medical-Inc.&v=1772513904987 "The graph of the company's future (projected) P/S Vivani Medical Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
Vivani Medical develops miniature implantable devices for long-term drug delivery. Its first product is designed to treat type 2 diabetes. The chart shows how investors estimate Vivani's future sales, reflecting the potential of its innovative technology, which could eliminate the need for frequent injections for patients.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772513905033 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
This chart reflects faith in innovations that can dramatically improve patients' quality of life. Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery, for example, for diabetes treatment. The potential of their technology to free patients from daily injections supports investor optimism in the long-term prospects of biotech.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513905044 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Vivani Medical Inc.
Vivani Medical is developing miniature implants for long-term drug delivery, specifically for the treatment of type 2 diabetes. As a preclinical company, it does not yet have commercial revenue. Its financial chart reflects investments in research and development, not cash flows from sales, which are only possible in the future.
Sales of companies in the market segment - Specialized medical equipment
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery. Its lead candidate is designed to treat type 2 diabetes and requires replacement only twice a year. This graph shows the total revenue in the specialized medical device sector, illustrating the company's commitment to improving patients' quality of life by reducing the frequency of injections.
Overall market sales
Vivani Medical is developing miniature implantable devices for long-term drug delivery, specifically for the treatment of type 2 diabetes. While in development, its cost depends on the success of the technology and clinical trials. This overall economic climate impacts the availability of funding for innovative medical developments with long R&D cycles.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Vivani Medical Inc.
Vivani Medical develops miniature subcutaneous implants for long-term drug delivery, for example, for the treatment of type 2 diabetes. The company's future depends on the success of clinical trials and approvals. The chart reflects speculative analyst forecasts, which are betting on a breakthrough in drug delivery systems.
%20sales%20of%20the%20company%20Vivani%20Medical%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Vivani-Medical-Inc.&v=1772513905142 "Schedule of future (projected) sales of the company Vivani Medical Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery, specifically for the treatment of type 2 diabetes. The technology is intended to replace daily injections. This chart shows projected sales for the entire specialized medical equipment segment, reflecting overall expectations for the drug delivery device market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772513905159 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Vivani Medical develops miniature implants for subcutaneous drug delivery aimed at treating chronic diseases such as diabetes. The company's future depends on the success of its technology and clinical trials. This overall economic activity schedule impacts the availability of venture capital needed to bring such innovative medical devices to market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513905182 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Vivani Medical Inc.
Vivani Medical develops miniature implantable devices for long-term drug delivery. This indicator reflects the financial impact of its innovations. It demonstrates the investment in development and clinical trials required to bring its unique technology to market and reach the future commercial stage.
Market segment marginality - Specialized medical equipment
Vivani Medical is developing miniature implants for long-term drug delivery, specifically for the treatment of type 2 diabetes. The profitability of this innovative technology will depend on the success of clinical trials. This metric reflects the company's operational structure during the R&D phase compared to other companies in the drug delivery system field.
Market marginality as a whole
Vivani Medical is developing miniature implantable devices for long-term drug delivery, for example, for the treatment of type 2 diabetes. Their technology could eliminate the need for frequent injections. Their success depends on clinical trials and regulatory approval. This overall profitability curve doesn't affect their R&D, but it is important for attracting investment.
Employees in the company, segment and market as a whole
Number of employees in the company Vivani Medical Inc.
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery. While still in the development stage, the company has a small but highly qualified team. This chart shows the dynamics of the team of engineers and scientists working on the development and preclinical testing of this innovative technology.
Share of the company's employees Vivani Medical Inc. within the market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery. This chart shows the concentration of unique engineers and pharmacologists working in the field of drug delivery systems. This share of such specialists reflects its innovative approach to treating chronic diseases such as diabetes.
Number of employees in the market segment - Specialized medical equipment
Vivani Medical, Inc. develops miniature implantable devices for long-term drug delivery. This chart shows overall employment in the specialized medical device sector. It illustrates the drive to develop new treatments for chronic diseases that could replace daily injections with implants that last for months.
Number of employees in the market as a whole
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery for chronic diseases such as diabetes. This innovative technology has the potential to improve patients' quality of life. This graph illustrates the job market, where the medical technology sector is constantly evolving, requiring engineers, chemists, and biocompatible materials specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Vivani Medical Inc. (VANI)
Vivani Medical, Inc. develops miniature implants for long-term drug delivery. This chart shows how the market values this breakthrough medical technology. The very high market capitalization per employee suggests that investors see enormous potential in this platform to transform the treatment of chronic diseases. The value here lies in patents, not employees.
%20of%20the%20company%20Vivani%20Medical%20Inc.%20(VANI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Vivani-Medical-Inc.-VANI&v=1772513905357 "Chart of market capitalization per employee (in thousands of dollars) of the company Vivani Medical Inc. (VANI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery. This innovative technology is at the intersection of pharmaceuticals and medical devices. This metric reflects the market premium placed on their breakthrough potential. The high market capitalization per employee reflects investors' belief that their technology will transform approaches to chronic disease treatment.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772513905361 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Vivani Medical, Inc. develops miniature implants for long-term drug delivery, for example, for diabetes treatment. It is a development-stage company. Its valuation is based on the potential of its technology. The high market capitalization per employee reflects investor expectations for a breakthrough product capable of significantly improving patients' quality of life.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513905362 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Vivani Medical Inc. (VANI)
Vivani Medical is a preclinical biotech company. They're developing tiny implants for long-term drug delivery (for example, to treat diabetes). This is pure R&D. This chart shows their capital burn rate: it measures the net loss (development costs) per scientist and engineer.
%20Chart%20Vivani%20Medical%20Inc.%20(VANI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Vivani-Medical-Inc.-VANI&v=1772513905391 "Company Profit Per Employee (in thousands of dollars) Chart Vivani Medical Inc. (VANI)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Vivani Medical is developing miniature subcutaneous implants for long-term drug delivery. For a company in the preclinical stage, this metric is irrelevant. The graph shows the industry norm. If their technology is successful, VANI will be able to license it, which would generate significant profits with minimal staffing, far exceeding the industry benchmark.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772513905396 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Vivani Medical (VANI) develops implantable devices for long-term drug delivery, for example, for the treatment of type 2 diabetes. Their business is complex medical R&D. This chart illustrates their current status: the company is in the development stage, and every employee (engineer, scientist) is an investment leading to negative returns.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513905427 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Vivani Medical Inc. (VANI)
For Vivani Medical, a company developing subcutaneous implants for long-term drug delivery, this graph reflects the development stage. Future revenue growth per employee will depend on the successful commercialization of its innovative platform for treating chronic diseases such as diabetes.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Vivani-Medical-Inc.-VANI&v=1772513905440 "Sales chart per company employee Vivani Medical Inc. (VANI)")
Sales per employee in the market segment - Specialized medical equipment
Vivani Medical develops miniature implants for long-term drug delivery, for example, for the treatment of type 2 diabetes. This is R&D in the medical equipment sector. This metric reflects the average revenue per employee in the segment. It helps assess how productive Vivani's R&D team is in advancing its technology compared to other companies in the field.
Sales per employee for the market as a whole
Vivani Medical (VANI) is a biopharmaceutical company developing miniature implants for long-term drug delivery (for example, for the treatment of type 2 diabetes). It is an R&D company. This indicator is an indicator of the future for VANI. Zero values currently reflect the R&D stage. An upward trend in the graph will indicate a commercial breakthrough and the success of their implant technology.
Short shares by company, segment and market as a whole
Shares shorted by company Vivani Medical Inc. (VANI)
Vivani Medical is developing miniature implants for long-term drug delivery, for example, for diabetes treatment. This is an interesting but speculative technology. This chart reflects investor bets that the company will encounter technological or regulatory hurdles in developing its implants or will fail to prove their superiority over existing treatments.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Vivani-Medical-Inc.-VANI&v=1772513905495 "Short Shares Chart for the Company Vivani Medical Inc. (VANI)")
Shares shorted by market segment - Specialized medical equipment
Vivani Medical (VANI) develops implantable devices for long-term drug delivery, including for the treatment of chronic obesity. This chart shows the overall short position in the specialty pharmaceuticals sector. It reflects market skepticism about the viability of implants in the era of highly effective injectable (GLP-1) weight loss drugs.
Shares shorted by the overall market
Vivani Medical (VANI) is a clinical-stage biotech developing implants. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Vivani Medical Inc. (VANI)
Vivani Medical (VANI) is a biotech company developing miniature implants for long-term (6+ months) drug delivery (for example, for diabetes). This is a bet on breakthrough technology. This chart measures the level of hype. It shows when the euphoria from announcements (overbought) or the despondency from delays (oversold) peaks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Vivani-Medical-Inc.-VANI&v=1772513905530 "RSI 14 indicator chart for the company's stock Vivani Medical Inc. (VANI)")
RSI 14 Market Segment - Specialized medical equipment
Vivani (VANI) — "medtech," an "implant" instead of an injection. They develop *mini-implants* (NPM-119) that *slowly* (6 months) *release* a drug for *diabetes* (GLP-1). The "Specialized medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is VANI's growth their "niche" or a general "overheating"?
RSI 14 for the overall market
Vivani Medical (VANI) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VANI (Vivani Medical Inc.)
Vivani Medical is a clinical-stage company developing miniature subcutaneous implants (NanoPortal) for sustained drug delivery, primarily for the treatment of type 2 diabetes (exenatide). This chart shows the speculative average price target from analysts based on the potential of this R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VANI-Vivani-Medical-Inc.&v=1772513905615 "A chart showing analyst consensus forecasts for the expected stock price. VANI (Vivani Medical Inc.)")
The difference between the consensus estimate and the actual stock price VANI (Vivani Medical Inc.)
Vivani Medical is a medical technology company developing long-lasting implants. Their flagship development is a six-month implant for the treatment of type 2 diabetes (based on GLP-1). This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their faith in this breakthrough technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VANI-Vivani-Medical-Inc.&v=1772513905654 "A chart showing the difference between the consensus forecast and the actual stock price. VANI (Vivani Medical Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Vivani Medical (VANI) is a biotech company developing tiny implants for long-term (6 months) drug delivery for chronic diseases such as type 2 diabetes. This chart shows general expectations for the specialized medical device sector. It reflects whether experts believe in this "mini-pump" technology.
Analysts' consensus forecast for the overall market share price
Vivani Medical is a company developing implants for long-term drug delivery. Their flagship project is an implant for the treatment of type 2 diabetes that needs to be replaced every six months. This chart shows the overall risk appetite. For Vivani, a company with a breakthrough but risky technology, overall market optimism is critical to raising capital for long-term clinical trials.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Vivani Medical Inc.
Vivani (VANI) is a biotech company focused on drug delivery. Their signature product is a long-term implant (NPM-119) that is inserted under the skin and automatically delivers medications (for example, for diabetes) over several months. This graph represents pure R&D investment. Its valuation reflects the market's belief that their implant (a competitor to Ozempic) will be effective and safe in the clinic.
AKIMA Market Segment Index - Specialized medical equipment
Vivani Medical develops miniaturized implants (NPM) for subcutaneous drug delivery, particularly for the treatment of chronic diseases such as diabetes. This chart shows the average index for the specialized medical device sector. It helps assess how Vivani's innovative technology compares to the average.
The AKIM Index for the overall market
Vivani Medical is a biopharmaceutical company developing miniature implants for long-term drug delivery (for diabetes and obesity treatment). This chart, which reflects the market average, provides context. It helps assess how this innovative platform, which addresses the issue of medication adherence, compares to overall macroeconomic trends.
